This Article Full Text Full Text (PDF) Other Versions of this Article: JVI.01924-06v1 81/8/4116    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Filippova, M. Articles by Duerksen-Hughes, P. J. Search for Related Content PubMed PubMed Citation Articles by Filippova, M. Articles by Duerksen-Hughes, P. J.

 Previous Article  |  Next Article 

Journal of Virology, April 2007, p. 4116-4129, Vol. 81, No. 8
0022-538X/07/$08.00+0     doi:10.1128/JVI.01924-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

The Large and Small Isoforms of Human Papillomavirus Type 16 E6 Bind to and Differentially Affect Procaspase 8 Stability and Activity

Department of Biochemistry and Microbiology, Loma Linda University School of Medicine, Loma Linda, California 92354

Received 4 September 2006/ Accepted 23 January 2007

Human papillomavirus type 16 (HPV-16) has developed numerous ways to modulate host-initiated immune mechanisms. The HPV-16 E6 oncoprotein, for example, can modulate the cellular level, and consequently the activity, of procaspase 8, thus modifying the cellular response to cytokines of the tumor necrosis factor family. E6 from HPV-16, but not E6 from the low-risk types 6b and 11, alters the cellular level of procaspase 8 in a dose-dependent manner. Both the large and small (E6*) isoforms of E6, which originate by way of alternate splicing, can modulate procaspase 8 stability. Intriguingly, although both isoforms bind to procaspase 8, the large isoform accelerates the degradation of procaspase 8 while the small isoform stabilizes it. Binding leads to a change in the ability of procaspase 8 to bind either to itself or to FADD (Fas-associated death domain), with the large version of E6 able to inhibit this binding while the small isoform does not. Consistent with this model, knockdown of the large version of E6 by small interfering RNA leads to increases in the levels of procaspase 8 and its binding to both itself and FADD. Thus, these alternatively spliced isoforms can modulate both the level and the activity of procaspase 8 in opposite directions.

Published ahead of print on 31 January 2007.